Title |
Calcium/calmodulin-dependent kinase II and Alzheimer’s disease
|
---|---|
Published in |
Molecular Brain, November 2015
|
DOI | 10.1186/s13041-015-0166-2 |
Pubmed ID | |
Authors |
Anshua Ghosh, Karl Peter Giese |
Abstract |
CaMKII is a remarkably complex protein kinase, known to have a fundamental role in synaptic plasticity and memory formation. Further, CaMKII has also been suggested to be a tau kinase. CaMKII dysregulation may therefore be a modulator of toxicity in Alzheimer's disease, a dementia characterised by aberrant calcium signalling, synapse and neuronal loss, and impaired memory. Here, we first examine the evidence for CaMKII dysregulation in Alzheimer's patients and draw parallels to findings in disease models which recapitulate key aspects of the disease. We then put forward the hypothesis that these changes critically contribute to neurodegeneration and memory impairment in Alzheimer's disease. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 7 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 86% |
Science communicators (journalists, bloggers, editors) | 1 | 14% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 190 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 41 | 22% |
Student > Bachelor | 30 | 16% |
Student > Master | 26 | 14% |
Researcher | 19 | 10% |
Student > Doctoral Student | 11 | 6% |
Other | 17 | 9% |
Unknown | 46 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 57 | 30% |
Biochemistry, Genetics and Molecular Biology | 31 | 16% |
Agricultural and Biological Sciences | 26 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 12 | 6% |
Medicine and Dentistry | 9 | 5% |
Other | 12 | 6% |
Unknown | 43 | 23% |